Microbix Biosystems Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Microbix Biosystems Inc with three other
miscellaneous service companies in North America:
Antibe Therapeutics Inc
sales of 8.51 million Canadian Dollars [US$6.43 million]
GW Pharmaceuticals PLC
of the United States
Kalvista Pharmaceuticals Inc
based in the United States
During the year ended September of 2018, sales at
Microbix Biosystems Inc were C$12.51 million (US$9.45 million).
increase of 22.8%
versus 2017, when the company's sales were C$10.19 million.
This was the fifth consecutive year of sales increases at Microbix Biosystems Inc
(and since 2013, sales have increased a total of 65%).